Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
XBB.1.5.29EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
XBB.1.5.29EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
XBB.1.5.29ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
XBB.1.5.29ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.38EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.38EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.38ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.38ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.38EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.38EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.38ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.38ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.160.14EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.160.14EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.160.14ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.160.14ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.160.14EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.160.14EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.160.14ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.160.14ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.297EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.297EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.297ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.297ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.297EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.297EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.297ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.297ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
AH.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
AH.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
AH.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
AH.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
AH.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
AH.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
AH.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
AH.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.1.280EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.1.280EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.1.280ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.1.280ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.1.280EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.1.280EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.1.280ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.1.280ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.597EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.597EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.597ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.597ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.597EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.597EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used